Indian pharmaceutical company Lupin (NSE:LUPIN, BOM:500257) has completed the acquisition of a 42.61% stake in renewable energy company Sunsure Solarpark Seventeen, according to a Thursday filing to the stock exchanges.
In September 2024, Lupin had agreed to acquire up to 42.61% stake in Sunsure Solarpark Seventeen for up to 105.53 million Indian rupees, to be completed in two tranches.
Price (INR): ₹2256.35, Change: ₹+3.5, Percent Change: +0.16%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。